Intracranial (IC) activity of ivonescimab (ivo) alone or in combination with platinum doublet chemotherapy (PC) in patients (Pts) with advanced non-small cell lung cancer (aNSCLC) and brain metastases (BMs)

Category Systematic review
JournalESMO Open
Year 2024
This article has no abstract
Epistemonikos ID: ffae048c16307702e6fe053928de7f13defab2b2
First added on: Feb 17, 2025